Danica Holley
CIK 1657320 · View on SEC EDGAR ↗
First SEC filing: Jan. 12, 2024 · Latest: Jan. 12, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 12, 2026 | XRN | P | 1,490 | $33.99 | $50,645 | 1,590 Direct | +1490.00% | Acquired | 8.2% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (2,270) | — | — | 2,270 | Acquired |
| Feb. 24, 2026 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (5,816) | — | — | 5,816 | Acquired |
| Feb. 26, 2025 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (8,770) | — | — | 8,770 | Acquired |
| Feb. 26, 2025 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (25,799) | — | — | 25,799 | Acquired |
| Feb. 21, 2024 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (11,486) | — | — | 11,486 | Acquired |
| Feb. 21, 2024 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (21,762) | — | — | 21,762 | Acquired |
| Jan. 10, 2024 | BEEP | Restricted Stock Units | Common Stock (29,168) | — | — | 29,168 | Acquired |
| Aug. 25, 2023 | BEEP | LTIP Units | Common Stock (10,088) | — | — | 10,088 | Acquired |
| Feb. 28, 2023 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (4,864) | — | — | 4,864 | Acquired |
| Feb. 23, 2023 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (15,996) | — | — | 15,996 | Acquired |
| March 4, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (13,246) | — | — | 13,246 | Acquired |
| Feb. 28, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (6,335) | — | — | 6,335 | Acquired |
| Feb. 24, 2022 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (6,191) | — | — | 6,191 | Acquired |
| May 26, 2021 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (5,630) | — | — | 5,630 | Acquired |
| March 2, 2021 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (20,402) | — | — | 20,402 | Acquired |
| March 2, 2021 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (18,520) | — | — | 18,520 | Acquired |
| July 9, 2020 | XRN | LTIP Unit [F1] | Common Stock (33,461) | — | — | 33,461 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock (20,780) | — | — | 20,780 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F3] | Common Stock (3,905) | — | — | 3,905 | Acquired |
| March 3, 2020 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (12,344) | — | — | 12,344 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F5] | Common Stock (2,100) | — | — | 2,100 | Acquired |
| March 5, 2019 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock (4,370) | — | — | 4,370 | Acquired |
| March 5, 2019 | XRN | LTIP Unit [F1] | Common Stock (8,578) | — | — | 8,578 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F4] | Common Stock (6,118) | — | — | 6,118 | Acquired |
| March 5, 2018 | XRN | LTIP Unit (Right to Buy) [F1] | Common Stock (7,076) | — | — | 7,076 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $325,000 | — | $454,000 | — | $156,780 | — | — | $935,780 |
| 2021 | $250,000 | — | $270,000 | — | $128,265 | — | — | $648,265 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.